![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 17, 14434-14442, April 26, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Genetics and Molecular Biology Program, Department of
Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson
University, Philadelphia, Pennsylvania 19107
Received for publication, October 12, 2001, and in revised form, February 7, 2002
Adenosine nucleotides affect the ability of
RecA·single-stranded DNA (ssDNA) nucleoprotein filaments to
cooperatively assume and maintain an extended structure that
facilitates DNA pairing during recombination. Here we have determined
that ADP and ATP/ATP Adenosine nucleotide binding and hydrolysis by the bacterial RecA
protein is crucial to mediate the formation, stability, and structure
of RecA·ssDNA1
(nucleoprotein) filament thought to be the key intermediate in the
initiation of recombination in vitro and in vivo
(1-3). Although hRAD51 is a homolog of RecA, the extent to which
adenosine nucleotides may modulate the formation, structure, and
stability of hRAD51 nucleoprotein filaments is unknown.
RecA couples the binding of ADP or ATP/ATP The ability of RecA to self-associate in the absence of DNA adds to the
complexity of RecA-ssDNA interactions. Several methods, including gel filtration chromatography, electron microscopy, light
scattering, and analytical ultracentrifugation, have demonstrated that
in the absence of DNA, RecA exists as dimers, trimers, small planar
hexameric-to-octameric rings, and short rods (13-15). Larger rods/filaments and bundles of filaments form in the presence of cations
(magnesium or spermidine) or concentrated solutions of RecA (16). While
the ability to self-associate appears to facilitate cooperative RecA
nucleoprotein filament assembly (17), the exact species of RecA that
binds to or dissociates from DNA is unknown. Moreover, beyond a certain
threshold of RecA self-association, DNA binding is significantly
reduced (18). Efficient DNA binding by RecA appears to involve prior
disassembly of self-aggregates to a relatively smaller species
(18-20). Both ATP and ADP reduce the size of self-aggregates (14, 16),
generating polymers ranging from hexamers to dodecamers in size (13).
However, only ATP (ATP Predicting the coordinate self-association, nucleotide
binding/hydrolysis, and ssDNA binding activity of hRAD51 based on a comparison with the RecA protein structure is not straightforward. The
RecA crystal structure indicated that residues involved in self-association, adenosine nucleotide binding/hydrolysis, and DNA
binding appeared juxtaposed and coordinated (21, 22). Genetic studies
indicated that RecA residues His97, Lys216,
Phe217, Arg222, and Lys248 are
involved in monomer-monomer contacts and are also proximal to the ADP
binding pocket as well as the unresolved loops implicated in DNA
binding (23, 24). It has been proposed that RecA residues Gln194 and Arg196 interact with the
Although these residues are highly conserved in the eubacterial RecA
family, an entirely different set of residues may substitute for their
functions in the eukaryotic RAD51 members (28). Only Arg222
and Gln194 appear conserved between RecA and hRAD51. In
addition, hRAD51 protein has an extended amino terminus and truncated
carboxyl terminus relative to the bacterial RecA (28, 29). The amino terminus of RecA forms extensive contacts between neighboring protomers
within a filament and is critical for self-association (30), while the
carboxyl terminus of RecA exists as a distinct domain that appears to
modulate DNA binding (31, 32). Interestingly, a study that combined NMR
and mutagenesis indicated that the extended amino terminus of hRAD51
may functionally replace the carboxyl-terminal domain of RecA (33).
Despite these differences, preliminary electron microscopy data have
indicated that hRAD51 forms planar hexameric-to-octameric ring
structures in the absence of DNA (34). In addition, nucleoprotein filaments formed in the presence of ATP Here we have examined the effects of ADP, ATP, and ATP Reagents--
Chemicals of the highest grade were obtained from
Amresco or Sigma. ADP and ATP were purchased from Amersham Biosciences
and processed as described (11). ATP Partial Proteolysis--
Approximately 10 µg of hRAD51 was
incubated in the standard buffer (20 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1 mM dithiothreitol,
0.1 mM EDTA) in 50 µl with 10 mM magnesium
acetate and 1 mM ATP, ADP, or ATP Analytical Gel Filtration--
100-200 µl of 8 µM hRAD51 was preincubated at 37 °C for 60 min in
modified H buffer with 2 mM magnesium acetate without
nucleoside or with 20 µM ATP IAsys Biosensor Studies--
IAsys biosensor (IAB) studies were
performed using an IAsys Auto+ unit (Affinity Sensors, Cambridge, UK).
A model oligonucleotide (oligo(dT)50) with either the
3'-end or 5'-end biotinylated (Glen Research; Sterling, VA) was
attached via streptavidin to the surface of an IAsys SPR cuvette
precoated with biotin (Affinity Sensors). The kinetics of hRAD51 DNA
binding were measured after the cuvettes were equilibrated in H buffer
containing the indicated amount of magnesium. The binding constant,
ka, was obtained directly from the slope of a plot
of the kon determined at multiple hRAD51 protein
concentrations. Dividing the kd, determined experimentally via IAB and averaged from several protein
concentrations, by the ka results in the
KD (KD = kd/ka). This method was also used
by DeZutter et al. (42) to determine the
KD for hRAD51 binding to an 83-mer random sequence oligonucleotide.
Gel Shifts--
Oligo(dT)50 binding was performed in
H buffer with 250 nM (nucleotide equivalents) of
oligo(dT)50 and the indicated amount of hRAD51. Reactions
were incubated as indicated in each figure legend and resolved by 4%
nondenaturing PAGE (acrylamide/bisacrylamide, 37.5:1; Amresco)
containing 0.5% glycerol. The system was buffered with 1× TBE, and
30-mA constant current was applied to each gel for ~2.5-3 h. The
gels were placed on Whatman No. 3MM paper, exposed directly (without
drying) to PhosphorImager screens (Molecular Dynamics, Inc., Sunnyvale,
CA), and scanned after overnight exposure. Care was taken not to
disrupt hRAD51·DNA aggregates remaining in the wells. We found that
if the gel is sufficiently wrapped to avoid contamination of the
PhosphorImager screen, it may be exposed without drying, and all of the
aggregate species will be retained.
Sedimentation Assay--
hRAD51 (0.5 µM) was
incubated with 5' end- 32P-labeled oligo(dT)50
(50 nM nucleotide equivalents) in 20 µl for 60 min at
37 °C in the standard H buffer with 10 mM magnesium
acetate in the absence of nucleotide or with either 20 or 500 µM of each adenosine nucleotide added, as indicated in
the figure legend. Each reaction was centrifuged in a microcentrifuge
at 14,000 rpm (~16,000 × g) for 30 min. The
supernatant (19 µl) was removed carefully and mixed with 5 ml of
Scintiverse mixture (Fisher) and counted. To the pellet, 100 µl of
10% SDS was added, and the sample was then vortexed, boiled, mixed
with 5 ml of Scintiverse, and counted.
DNA Binding by hRAD51
IAsys Biosensor Studies--
IAB is capable of detecting real time
interactions between molecules. We have developed a system in which a
model oligonucleotide (oligo(dT)50) is biotinylated at
either the 3'- or 5'-end and attached via a streptavidin linkage to an
IAB cuvette coated with biotin.
We obtained KD values for
hRAD51·oligo(dT)50 binding in the range of 78-176
nM depending upon the magnesium concentration or whether
the 5'- or 3'-biotinylated substrate was examined (Table I). These results largely resemble a
previous study that measured the interaction of hRAD51 with ssDNA
(a random sequence 83-mer oligonucleotide) by IAB (42). Modest
differences between these studies may be attributed to the size and/or
nature of the secondary structure present in the two substrate DNAs or
the different buffer conditions. We observed that 3'-biotinylated
oligo(dT)50 (3'-end attached to the IAB cuvette surface)
consistently displayed a lower KD that could be
largely attributed to an increased ka. These results
suggest that hRAD51 can bind ssDNA displaying either a free 5'-end or
3'-end but that it exhibited a modest preference for binding DNA
displaying a free 5'-end.
hRAD51 (maintained at 4 °C) readily bound the
oligo(dT)50 IAB DNA substrate in the absence of adenosine
nucleotide as well as in the presence of ADP or ATP
(Bmax
We compared the binding of the oligo(dT)50 IAB DNA
substrate by hRAD51 to the binding of this substrate by RecA. ATP
We determined the amount of ADP (IC50 Gel Shift Studies--
The effect of ADP, ATP, or ATP
Gel shift analysis following preincubation of hRAD51 at 37 °C in the
absence or presence of ADP, ATP, or ATP
We examined the effect of ADP, ATP, and ATP
Our previous studies have demonstrated that binding of ADP to hRAD51
displayed two distinct modes: one mode with a high affinity for ADP
(Kapp1
The apparent replacement of ADP by ATP Sedimentation Assay--
The RecA protein has been found to form
aggregates and co-aggregates with ssDNA and dsDNA. The RecA/DNA
co-aggregates appeared to be intermediates in the homologous pairing
process and could be easily pelleted (43). Although a comparison
between these structures and the hRAD51·DNAhigh
aggregates would be premature, we reasoned that a similar
co-sedimentation assay in the presence of ADP, ATP, or ATP Adenosine Nucleotides Induce Conformational Transitions in
hRAD51
Partial proteolysis has been a useful method for determining
conformational transitions associated with nucleotide-binding proteins,
including RecA (44). hRAD51 was preincubated with ADP, ATP, or ATP
Biochemical Characterization of the Human RAD51 Protein
III. MODULATION OF DNA BINDING BY ADENOSINE NUCLEOTIDES*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
S affect the DNA binding and aggregation
properties of the human RecA homolog human RAD51 protein (hRAD51).
These studies have revealed significant differences between hRAD51 and
RecA. In the presence of ATP
S, RecA forms a stable complex with
ssDNA, while the hRAD51 ssDNA complex is destabilized. Conversely, in
the presence of ADP and ATP, the RecA ssDNA complex is unstable, while
the hRAD51 ssDNA complex is stabilized. We identified two
hRAD51·ssDNA binding forms by gel shift analysis, which were distinct
from a well defined RecA·ssDNA binding form. The available evidence suggests that a low molecular weight hRAD51·ssDNA binding form (hRAD51·ssDNAlow) correlates with active ADP and
ATP processing. A high molecular weight hRAD51·ssDNA aggregate
(hRAD51·ssDNAhigh) appears to correlate with a form that
fails to process ADP and ATP. Our data are consistent with the notion
that hRAD51 is unable to appropriately coordinate ssDNA binding with
adenosine nucleotide processing. These observations suggest that other
factors may assist hRAD51 in order to mirror RecA recombinational function.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
S with the binding to DNA.
In the presence of ATP
S, RecA binds to ssDNA in a highly cooperative, largely irreversible manner and extends the helical pitch
of the DNA to ~1.5 times its normal length (4-7). Reciprocally, ssDNA increases the affinity of RecA for ATP
S (8). In the presence
of ADP, RecA binding to ssDNA is unstable, and the filament is less
extended/inactive (4-6). Similarly, ssDNA decreases the affinity of
RecA for ADP (9). In contrast, both ssDNA and dsDNA failed to affect
ATP
S binding or ADP release by hRAD51 (10). Moreover, hRAD51 appears
to lack ATP-induced cooperativity during ATP hydrolysis (11) and/or the
ability to form extended/active hRAD51·ssDNA nucleoprotein
filaments in the presence of ATP
S (12). These data suggest that
hRAD51 differs significantly from RecA in its ability to couple ADP and
ATP/ATP
S processing with ssDNA interactions.
S) efficiently activates RecA DNA
binding activity (4-6). Little is known about the effect of ADP, ATP,
or ATP
S on the conformation of hRAD51, its ability to form
self-polymers, or its ability to assume and maintain an active
hRAD51·ssDNA nucleoprotein filament.
-phosphate of ATP to coordinate DNA binding by loop L2 (residues
195-210) with ATP hydrolysis (25, 26). Moreover, Hörtnagel
et al. (26) suggested that Arg196 may
participate catalytically in ATP hydrolysis in a manner similar to the
"arginine finger" of GTPase activator proteins (27). These
residues appear critical for biological activity and probably function
as allosteric effectors of the ATP-induced active form of the RecA
nucleoprotein filament (23, 24).
S with ssDNA grossly resemble inactive/compact RecA nucleoprotein filaments (12). In contrast, neutron scattering performed on Xenopus laevis RAD51
suggested that an extended filament may form on ssDNA in the presence
of ATP or ADP but less well with ATP
S (35). Interestingly, hRAD51 forms an extended nucleoprotein filament with the transition state mimetic ADP-AlF
S for DNA strand exchange (37).
S on hRAD51
ssDNA binding activity. We find significant differences in the effects
of these adenosine nucleotides on the ssDNA binding activity of hRAD51
compared with RecA. Unlike RecA, hRAD51 binding of ADP, ATP, or ATP
S
is not coupled to modulation of ssDNA binding activity. In addition,
hRAD51 appears largely unable to discriminate ADP, ATP, or ATP
S. It
is likely that the inability of RAD51 to efficiently process adenosine
nucleotides underpins the lack of coordination between protomers during
ATP hydrolysis. We propose that inefficient ATP processing contributes
to a reduced rate of DNA strand exchange and a dramatically reduced
ability to bypass heterologous DNA during strand exchange (38-41).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
S was purchased from Roche Molecular Biochemicals. Sequencing grade endoprotease Lys-C and trypsin
were purchased from Promega or Roche Molecular Biochemicals and
resuspended in modified H buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM dithiothreitol, 10% glycerol,
without EDTA) at a stock concentration of 200 ng/µl just prior to
use. Oligo(dT)50 was synthesized at the Kimmel Nucleic
Acids Facility. IAsys cuvettes coated with biotin were purchased from
Affinity Sensors (Cambridge, UK), and 5' or 3' biotinylated
oligo(dT)50 was purchased from Glenn Research (Sterling,
VA). hRAD51 was purified as described (11). RecA protein was purchased
from U.S. Biochemical Corp.
S at 37 °C for 30 min in an Ericomp thermal cycler with heated lid to prevent
evaporation. Then 6-µl aliquots were added to 6 µl of various
protease dilutions. Shown are digests containing either 220 ng of
endoprotease Lys-C or 220 ng of trypsin. Protease incubations continued
at 37 °C for an additional 60 min. Reactions were stopped by the
addition of 4 µl of 4× loading buffer (0.2 M Tris-HCl
(pH 7.0), 8% SDS, 20%
-mercaptoethanol, 20% sucrose, 2 mg/ml
bromophenol blue) and followed by boiling. Proteolytic products of
hRAD51 were resolved by 20% SDS-PAGE and silver-stained. Gels were
wrapped in clear plastic wrap and scanned directly with an Epson scanner.
S or 20 µM
ADP. A Superose-12 column (10/30; Amersham Biosciences) was
equilibrated in the same buffer. hRAD51 was eluted at a flow rate of 24 ml/h, and 0.5-ml fractions were collected. 1 µg of acetylated bovine
serum albumin (New England Biolabs) and 0.5 ml of 1 M
trichloroacetic acid were added to each fraction, followed by overnight
precipitation at
20 °C. The precipitated proteins were then
pelleted, washed with ice-cold acetone, air-dried, and resuspended in
loading buffer (0.05 M Tris-HCl (pH 7.0), 2% SDS, 5%
-mercaptoethanol, 5% sucrose, 0.5 mg/ml bromophenol blue).
Approximately half of the precipitate was resolved by 10% SDS-PAGE and
silver-stained.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Summary IAsys DNA binding data for hRAD51 in the absence of adenosine
nucleotides
1000 arc s for each; Fig.
1A). Moderately less efficient
binding was observed in the presence of ATP
S
(Bmax
500 arc s; Fig. 1A). When
hRAD51 was preincubated at 37 °C for 30 min in the absence of
adenosine nucleotide, it failed to bind the oligo(dT)50 IAB
DNA substrate (Bmax < 100 arc s; Fig. 1,
compare A and C). However, when ADP, ATP,
or ATP
S was present during the preincubation, binding to the
oligo(dT)50 IAB DNA substrate by hRAD51 preincubated at
37 °C appeared almost identical to the binding displayed by hRAD51,
which was maintained at 4 °C (Bmax
1000 arc s; Fig. 1, compare A and C). These
observations suggest that incubation of hRAD51 at 37 °C results in a
form that is largely incapable of ssDNA binding.

View larger version (22K):
[in a new window]
Fig. 1.
Comparative effects of adenosine nucleotides
on ssDNA binding by hRAD51 and RecA. IAsys biosensor analysis was
used to compare the binding of 125 nM hRAD51 (A
and C) or 250 nM RecA (B and
D) to a model ssDNA substrate (oligo(dT)50) in
the presence of 10 mM Mg2+ and in the absence
or presence of 1 mM ADP, ATP, or ATP
S. Prior to the
addition of proteins, IAsys cuvettes with covalently attached biotin
were precoated with streptavidin followed by oligo(dT)50
containing a 5' biotin. In A and B, the
protein/nucleotide mix was added to the cuvette directly, whereas in
C and D, each protein/nucleotide mix was
preincubated at 37 °C for 30 min prior to the addition to the
cuvette.
S
promoted the most stable interaction of RecA with the
oligo(dT)50 IAB DNA substrate (Bmax
900 arc s; Fig. 2B). RecA
binding in the absence of adenosine nucleotide was slightly less
efficient (Bmax
500 arc s; Fig.
1B). Under our conditions (150 mM NaCl), RecA
failed to bind the oligo(dT)50 IAB DNA substrate in the
presence of ATP or ADP (Bmax < 100 arc s; Fig.
1B). These results are qualitatively and quantitatively
similar to previously published reports (4-7, 42). Moreover, RecA
binding appeared identical regardless of the preincubation conditions
(Fig. 1, compare B with D). These observations
underline the inherent differences in ssDNA binding between RecA and
hRAD51.

View larger version (18K):
[in a new window]
Fig. 2.
Adenosine nucleotides preserve
hRAD51·oligo(dT)50 binding activity.
Reactions were performed as in Fig. 1C except that the
indicated amount of ATP (A) or ADP (B) was
substituted during the 30-min preincubation period. Each
point represents the maximal bound. Each bar
represents the average of three experiments.
1 µM) or ATP (IC50
0.2 µM)
required to preserve half-maximal hRAD51·oligo(dT)50 IAB DNA binding activity (Fig. 2). The IC50 values appear
significantly less than the binding constant determined for ADP or
ATP
S to hRAD51 (KD
5 µM) (10).
These data appear to suggest that only a subset of hRAD51 protomers
must be bound by ADP or ATP to preserve DNA binding activity. AMP did
not significantly preserve DNA binding (data not shown), suggesting
that the
-phosphate of ADP is minimally required to preserve
oligo(dT)50 IAB DNA binding activity. These observations
are consistent with a significantly reduced affinity of hRAD51 for AMP
(10).
S on the
interaction of hRAD51 with oligo(dT)50 was also examined by
gel shift analysis. hRAD51 appears to form at least two qualitatively
different forms when bound to the model oligo(dT)50 ssDNA
substrate, which we denote hRAD51·DNAlow and
hRAD51·DNAhigh (Fig. 3,
A and B). Moreover, the migration of the hRAD51
forms appears distinct from RecA·oligo(dT)50 gel shift
complexes produced under identical conditions (compare Fig. 3,
A and B, with Fig. 3C). The structure
of these forms is unknown. The hRAD51·DNAlow form appears
be a low molecular weight complex that migrates slightly more slowly
than free oligo(dT)50 (denoted by an asterisk;
Fig. 3, A and B). The
hRAD51·DNAhigh form is a significantly larger complex
(Fig. 3, A and B). The relative amount of these
forms appears to be modulated by ADP, ATP, and ATP
S. In the absence
of ADP, ATP, and ATP
S, hRAD51·DNAlow is the singular
gel shift form (Fig. 3A, lanes 1-5).
In contrast, the addition of 1 mM ADP, ATP, and ATP
S
induces the formation of hRAD51·DNAhigh (Fig.
3A, lanes 6-10). The relative amount
of the hRAD51·DNAhigh form depends on the type of
adenosine nucleotide, where ADP > ATP
S
ATP (Fig.
3A, lanes 6-10 > lanes 16-20
lanes 11-15). By quantitating the ratio of free DNA to bound DNA
(where bound represents both forms), we calculate a
KD(hRAD51)
0.3 µM for
binding to the oligo(dT)50 ssDNA substrate in the presence
of ADP or ATP or in the absence of adenosine nucleotide (Fig.
3A, lanes 6-10, lanes
11-15, or lanes 1-5). In the
presence of ATP
S, hRAD51 displayed a reduced affinity for the
oligo(dT)50 ssDNA substrate
(KD(hRAD51)
0.5 µM;
Fig. 3A, lanes 16-20).

View larger version (67K):
[in a new window]
Fig. 3.
Gel shift analysis of hRAD51 and RecA binding
to oligo(dT)50. A, the indicated amount of
hRAD51 (µM) was incubated with oligo(dT)50
(250 nM) for 60 min at 37 °C in the absence or presence
of 1 mM ADP, ATP, or ATP
S and then resolved by 4%
nondenaturing PAGE. B, reactions are identical to
A except that hRAD51 was preincubated in the absence or
presence of adenosine nucleotide for 30 min at 37 °C and
subsequently mixed with oligo(dT)50. These were incubated
at 37 °C for an additional 20 min and then resolved by 4%
nondenaturing PAGE. C, reactions were identical to
A except that the indicated amount of RecA
(µM) was substituted for hRAD51. Two different
hRAD51·oligo(dT)50 complexes are indicated by
low and high; an asterisk indicates
free oligo(dT)50. N, reactions lacking hRAD51 or
RecA.
S also resulted in a DNA
binding pattern qualitatively similar to IAB (compare Fig. 1,
A and C, with Fig. 3, A and
B). In the absence of adenosine nucleotide, hRAD51 appeared
to be largely inactivated, since DNA binding was only observed at very
high concentrations of hRAD51 (Fig. 3B, lanes
1-5). Under these conditions, the
KD(hRAD51) did not appear to change when
nucleotide was included (similar to IAB). However, a significant
increase in the hRAD51·DNAhigh form and coincident
decrease in the hRAD51·DNAlow form occurred in the
presence of ADP (Fig. 3B, lanes
6-10). A similar but less striking effect occurred in the
presence of ATP
S (Fig. 3B, lanes 16-20). In the presence of ATP, the distribution between
forms appeared to remain unchanged (Fig. 3B,
lanes 11-15).
S on hRAD51 binding to
the oligo(dT)50 ssDNA substrate by gel shift analysis. These studies were performed at a concentration of hRAD51 (0.3 µM) that largely generated the
hRAD51·DNAlow form and minimized the production of
aggregates (hRAD51·DNAhigh). We found that ADP, ATP,
or ATP
S enhanced the formation of hRAD51·DNAlow
(KD(NUC)
1 µM; Fig.
4, A-C). Above 250 µM ADP, ATP, or ATP
S, the effect of these nucleotides
appears more complex (Fig. 4). ADP promotes the production of the
hRAD51·DNAhigh form (Fig. 4A). ATP (Fig. 4B) and ATP
S (Fig. 4C) promote the
dissociation of a fraction of the hRAD51·DNAlow form.
Both gel shift analysis and IAB confirm the apparent equivalent high
affinity of adenosine nucleotides for hRAD51. These results also
suggest that the type of hRAD51·ssDNA form generated is influenced by
adenosine nucleotides. Interestingly, dsDNA does not appear to form
hRAD51·DNAhigh structures similar to ssDNA (data not
shown).

View larger version (37K):
[in a new window]
Fig. 4.
Saturation of the hRAD51 high affinity
adenosine nucleotide binding site (KD
5 µM) enhances
the formation of the hRAD51·DNAlow species. hRAD51
(0.3 µM) was mixed with the indicated amount of each
adenosine nucleotide and 250 nM oligo(dT)50
(nucleotides), incubated at 37 °C for 30 min, and subsequently
resolved by 4% nondenaturing PAGE. An asterisk indicates
the position of free oligo(dT)50 DNA.
5 µM), which appeared
competitive with ATP, and a second low affinity mode
(Kapp2
125 µM) (10). The first mode (Kapp1
5 µM) appeared to
be competent for ADP
ATP exchange with a t1/2
30 s, whereas the second mode (Kapp2
125 µM) appeared refractory for ADP
ATP exchange (10). We found that the formation of hRAD51·DNAhigh
correlated well with the expected Kapp2
125 µM (Fig. 5A).
Furthermore, there appears to be a transition from
hRAD51·DNAlow to hRAD51·DNAhigh in our gel
shift analysis with increasing ADP saturation (Fig. 5A).
When 5 mM ATP
S was added subsequent to ADP in these
DNA-binding reactions, the hRAD51·DNAlow form
dissociated, while the hRAD51·DNAhigh form remained
unchanged (Fig. 5, compare A and B). Moreover,
once formed, hRAD51·DNAhigh aggregate appears stable and
irreversible (data not shown). Taken together, these results
demonstrate that ADP, ATP, and ATP
S modulate the
hRAD51·DNAlow form. However, the
hRAD51·DNAhigh form is likely to be a "dead end"
complex that may only be significant for in vitro
assays.

View larger version (66K):
[in a new window]
Fig. 5.
Adenosine nucleotides affect the formation
and stability of hRAD51·DNAlow and
hRAD51·DNAhigh complexes. A, hRAD51 (0.5 µM), the indicated amount of ADP, and 250 nM
oligo(dT)50 (nucleotides) were incubated at 37 °C for 60 min and then resolved by 4% nondenaturing PAGE. B,
reactions were performed as in A except that 5 mM ATP
S was added subsequent to the initial 60-min
incubation, and the incubation was continued for an additional 20 min
at 37 °C prior to PAGE. C and D, reactions
were performed as in B except that the initial incubation
contained 20 µM ADP, and the indicated amount of ATP
S
(C) or ATP (D) was added subsequently. An
asterisk indicates the position of free
oligo(dT)50 DNA. For C and D, the
relative species denoted by an asterisk and low
were quantitated by a PhosphorImager, and the data were fit to a curve
by nonlinear regression. The resulting curves are displayed
below their respective gels.
S that resulted in the
destabilization of hRAD51·DNAlow occurred with a
Ki·ATP
S
100 µM and
translated to a ratio of 1 ADP/4-5 ATP
S (Fig. 5C). ATP
appeared significantly less effective in destabilizing the hRAD51·DNAlow form (Ki·ATP
250 µM; Fig. 5D). The amount of ATP (ATP
S)
required to destabilize the hRAD51·DNAlow form generated
in the presence of ADP is similar to that required for the
destabilization of hRAD51·DNAlow in the absence of
ADP (Fig. 4, B and C). These results suggest that
a specific ratio of ADP/ATP (ATP
S) may not be required for efficient dissociation.
S would be
useful for the analysis of the hRAD51·DNAhigh form.
The addition of hRAD51 resulted in co-sedimentation of the
32P-labeled oligo(dT)50 ssDNA substrate in the
presence of 500 µM ADP (Fig.
6B). No co-sedimentation was
observed in the absence of adenosine nucleotide (Fig. 6A),
in the presence of 20 µM ADP (Fig. 6B), or in
the presence of either 20 or 500 µM ATP/ATP
S (Fig. 6,
C and D). These results are consistent with the
hRAD51 oligo(dT)50 ssDNA gel shift analysis and suggest
that hRAD51 forms a hRAD51-ssDNA aggregate at supersaturating
concentrations of ADP.

View larger version (21K):
[in a new window]
Fig. 6.
hRAD51 and oligo(dT)50 form large
complexes in the presence of high ADP concentrations. To further
characterize hRAD51·oligo(dT)50 complexes, the ability to
co-sediment in the absence or presence of adenosine nucleotides was
examined. hRAD51 (5-500 nM) and oligo(dT)50
(50 nM) were incubated at 37 °C for 60 min in the
absence of nucleotide (A) or in the presence of 20 or 500 µM ADP (B), ATP (C), or ATP
S
(D). After centrifugation at 16,000 × g for
30 min at room temperature, counts retained in the supernatant
(sup) and pellet were determined. Each point
represents the average of three experiments.
S
and subsequently exposed to a limiting amount of either endoprotease
Lys-C or trypsin. Partial proteolysis by both endoprotease Lys-C and
trypsin suggest that ADP, ATP, and ATP
S induced conformational
transitions in hRAD51 that were distinct from the pattern exhibited in
the absence of adenosine nucleotide (Fig.
7, A and B).
Endoprotease Lys-C generates two distinct peptides (denoted by
arrows in Fig. 7A) of ~15-20 kDa that were
evident when hRAD51 was incubated with buffer only but not detectable in the presence of ADP, ATP, or ATP
S. Partial trypsin digestion generated two distinct peptides of ~25-30 kDa (see arrows
in Fig. 7B) that were prominent when ADP, ATP, or ATP
S
was added but not detectable in the presence of buffer alone. The
specific location of these peptides within the hRAD51 protein is
currently under investigation. The appearance of these partial
proteolysis peptides corresponded with the ADP, ATP, and ATP
S
binding affinity (KD
5 µM; data
not shown), and the peptide banding pattern did not appear to differ
between adenosine nucleotides. In the absence of protease only
full-length hRAD51 was observed, and in the absence of hRAD51 there
were no peptide products (data not shown). These results indicate that
ADP, ATP, or ATP
S affects the susceptibility of hRAD51 to protease,
suggesting alternate conformations.

View larger version (82K):
[in a new window]
Fig. 7.
Adenosine nucleotides affect hRAD51
sensitivity to limited proteolysis and the ability to
self-associate. Limited proteolysis (A and
B) and analytical gel filtration (C) were
performed to examine the effects of adenosine nucleotides on hRAD51
structure. For proteolysis, ~10 µg of hRAD51 was preincubated at
37 °C for 30 min in the absence or presence of a 1 mM
concentration of the indicated adenosine nucleotide. These were
subsequently divided into two 5-µg portions and treated with either
endoproteinase Lys-C (A) or sequencing grade trypsin
(B). Proteolysis products were resolved by 20% SDS-PAGE
followed by silver staining. C, hRAD51 (8 µM)
was preincubated at 37 °C for 60 min in the absence or presence of
20 µM ADP or ATP
S and subsequently resolved by elution
through a Superose 12 column equilibrated with the same buffer. Each
fraction was precipitated with trichloroacetic acid and analyzed by
10% SDS-PAGE followed by silver staining. Relative molecular weights
were determined with gel filtration standards (Bio-Rad) and are
indicated above the fraction numbers.
Adenosine Nucleotides Affect hRAD51 Self-association
Analytical gel filtration chromatography has been used to determine higher order protomer complexes of the bacterial RecA protein (15). In the absence of adenosine nucleotides, analytical gel filtration at 4 °C suggests that hRAD51 self-associates to form a protein species that appears to migrate with the relative molecular weight of hexamers to dodecamers (data not shown). These protein species may resemble the hRAD51 hexameric/octameric rings observed previously by electron microscopy (34). In contrast, incubation of hRAD51 at 37 °C in the absence of adenosine nucleotide results in an apparent high molecular weight species of hRAD51 (Fig. 7C). A fraction of these complexes are found in the void volume of the gel filtration column that was determined to exclude proteins of ~1 MDa. This result suggests that at 37 °C in the absence of adenosine nucleotide, hRAD51 forms higher order self-association complexes similar to RecA. The detailed structure of these complexes is unknown. It is interesting to note that our chromatography buffer contained 150 mM NaCl, which is inhibitory to the self-association/polymerization of RecA (15). The ability of hRAD51 to aggregate in the presence of physiological salt concentration appears similar to C-terminally truncated mutants of RecA (45) and X. laevis RAD51 (35). These results suggest that hRAD51 may possess an increased intrinsic potential to aggregate.
Chromatography of hRAD51 in the presence of either 20 µM
ADP or ATP
S results in protein species that appear to elute
with an average molecular mass of 100-250 kDa, corresponding to
3-8 hRAD51 monomers (Fig. 7C). These results suggest that
the addition of ADP or ATP
S significantly reduced the size of the
nucleotide-free hRAD51 aggregates. The amount of ADP or ATP
S
required for this reduction correlated with the previously identified
hRAD51 high affinity binding mode (KD
5 µM; Fig. 7C and Ref. 10). These results
suggest that both ADP and ATP are capable of modulating the size of
hRAD51 polymers.
| |
DISCUSSION |
|---|
|
|
|---|
Bacterial RecA protein cooperatively binds and hydrolyzes ATP in a
process that is intrinsically linked to the structure/stability of a
RecA·ssDNA nucleoprotein filament (1, 3). These observations have
been described in terms of a "coupled cycle." Several studies have
shown that a tight association exists between ATP/ATP
S-bound RecA
and ssDNA and a weak association exists between ADP-bound RecA and
ssDNA (1, 3). Cooperative interactions between ATP-bound RecA protomers
within this nucleoprotein filament appear to facilitate ADP
ATP
exchange and drive the RecA ATPase cycle. The hRAD51 ATPase lacks the
magnitude of ATP-induced cooperativity displayed by RecA (11).
Moreover, ssDNA does not affect the affinity of hRAD51 for ADP or
ATP/ATP
S (10). These observations have suggested that hRAD51 may not
couple adenosine nucleotide processing and DNA binding similar to RecA.
We have examined the effect of ADP, ATP, or ATP
S on hRAD51 ssDNA
binding by IAB as well as gel shift (GS) analysis. In the absence of
adenosine nucleotide, hRAD51 exhibited an enhanced affinity for a model
oligo(dT)50 ssDNA substrate compared with RecA. The effect
of ADP, ATP, and ATP
S on hRAD51 ssDNA binding appeared nearly
opposite to RecA. Unlike RecA, and consistent with a previous report,
hRAD51 displayed reduced affinity for ssDNA in the presence of ATP
S
(42). We now report that hRAD51 ssDNA binding was unaffected by ADP and
ATP. This contrasts with the reduced or absent RecA ssDNA binding
activity in the presence of ADP and ATP (see Figs. 1 and 3) (4-7, 42).
These results suggest a fundamental difference between RecA and hRAD51
in the effect of ADP, ATP, and ATP
S on ssDNA binding functions.
A temperature-dependent inactivation of hRAD51 ssDNA
binding activity was observed using both IAB and GS analysis.
Saccharomyces cerevisiae RAD51 also exhibits a
temperature-dependent inactivation of ssDNA binding
activity (46). Maintaining the yeast RAD51 in the presence of ATP
(KD(ATP)
20 µM) or ADP
(KD(ADP)
250 µM)
appeared to preserve the ssDNA binding activity (46). In contrast,
hRAD51 required significantly less ATP
(KD(ATP)
0.1 µM) or
ADP (Kapp1
5.0 µM) to preserve
ssDNA binding activity. The amount of ATP required to preserve hRAD51
ssDNA binding activity is 20-fold below the
KD(ATP). These data suggest that preservation of hRAD51 ssDNA binding activity at elevated temperatures does not require saturation of the protein with ATP. The difference between ATP and ADP preservation of hRAD51 ssDNA binding activity is unknown.
The temperature inactivation of hRAD51 ssDNA binding activity in the
absence of ADP, ATP, or ATP
S correlates with the appearance of a
high molecular mass (
670 kDa) aggregate by gel filtration (see Fig.
7C). In the presence of ADP and ATP
S, hRAD51 is resolved into smaller complexes (~40-200 kDa) that correlate with ssDNA binding activity (see Fig. 7C). These results are consistent
with the notion of self-aggregation of hRAD51 in the absence of
adenosine nucleotide. An aggregation effect that is competitive with
ssDNA binding has been observed with RecA (18, 19). In the case of
hRAD51, the aggregate appears irreversible and is only likely to
be relevant to in vitro assays. It is also theoretically
possible that the ADP-dependent irreversible
self-association/aggregation of hRAD51 may be modulated by other
protein factors
GS analysis of hRAD51·ssDNA complexes identified two qualitatively different hRAD51·oligo(dT)50 complexes: a fast mobility, apparently low molecular weight form (denoted hRAD51·DNAlow) and a slow mobility, apparently high molecular weight aggregate form (denoted hRAD51·DNAhigh). While the precise nature of these forms is unknown, the mobilities of the hRAD51·ssDNA forms are distinct from the RecA·ssDNA complex. Since the molecular weights of RecA and hRAD51 are equivalent, it is tempting to speculate that there is significantly less hRAD51 protein in the hRAD51·DNAlow form than RecA protein in the RecA·ssDNA complex.
There does not appear to be a clear correlation between IAB
hRAD51·ssDNA complexes and GS hRAD51·ssDNA forms. In general, it
appears that the IAB hRAD51·ssDNA complexes are representative of
both the GS hRAD51·DNAlow and
hRAD51·DNAhigh forms. The cumulative GS binding of
hRAD51·ssDNA in both the low and high mobility forms appears to be
equivalent to the results obtained with IAB. However, we have found
that only the hRAD51·DNAlow form appears capable of
adenosine nucleotide processing. For example, the subsequent addition
of ATP
S dissociates the hRAD51·DNAlow form but not the hRAD51·DNAhigh form (see Fig. 5). In addition, ADP
ATP exchange can be measured at low ADP concentrations (20 µM) when the hRAD51·DNAlow form appears to
be exclusive (10). However, we were unable to detect ADP
ATP
exchange by hRAD51 at high ADP concentrations (200 µM)
when it is largely in the hRAD51·DNAhigh form (10). These
results are consistent with the notion that the
hRAD51·DNAlow form is active for both adenosine
nucleotide processing and ssDNA binding. It is likely that the
hRAD51·DNAhigh form represents an aggregate structure.
This conclusion is based on its inability to enter the gel matrix and
our finding that it can be pelleted by centrifugation. Since this
hRAD51·DNAhigh form appears irreversible and correlates
with a secondary nonsaturable mode of ADP binding (see Ref. 10), it is
likely to be a nonspecific aggregate that is only important for
in vitro studies where incubation times exceed 1 h or
where the formation of significant levels of ADP occur. Such conditions
may be routinely used in hRAD51-mediated strand exchange studies.
RecA efficiently discriminates ADP, ATP, and ATP
S (1). This
discrimination is manifest in cooperative ATP hydrolysis and recombinational strand exchange. In contrast, hRAD51 is unable to
adequately differentiate ADP, ATP, and ATP
S. IAB and GS studies indicate that hRAD51 forms similar ssDNA complexes in the presence of
all three of these adenosine nucleotides (below 150 µM).
In addition, the hRAD51 binding constant (KD or
Kapp1) for ATP/ATP
S and ADP is equivalent.
Under similar circumstances, RecA is capable of discriminating between
ADP and ATP/ATP
S as well as between ATP and ATP
S. The inability
to efficiently discriminate between adenosine nucleotides provides a
foundation for the idea that hRAD51 function(s) requires additional
protein factors to duplicate RecA function(s). Potential candidates for
hRAD51 co-factor(s) are one or all of the known mitotic or meiotic
human RecA homologs: hRAD51B, hRAD51C, hRAD51D, XRCC2, XRCC3, and hDMC1
(47-49).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Hans-Jürg Alder and the Kimmel Nucleic Acids Facility for oligonucleotide synthesis and sequencing, and we thank Chris Schmutte, Samir Acharya, Scott Gradia, and Kristine Yoder for helpful discussions and careful review of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by National Research Service Award Grant 5-T32-CA09678 (to G. T.) and National Institutes of Health Grant CA56542 (to R. F.).
To whom correspondence and reprint requests should be addressed:
Kimmel Cancer Center, BLSB933, 233 S. 10th St., Philadelphia, PA 19107. Tel.: 213-503-1346; Fax: 215-923-1098; E-mail: rfishel@ hendrix.jci.tju.edu.
Published, JBC Papers in Press, February 11, 2002, DOI 10.1074/jbc.M109917200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
ssDNA, single-stranded DNA;
dsDNA, double-stranded DNA;
ATPase, ATP hydrolysis
activity;
hRAD51, human RAD51 protein;
ATP
S, adenosine
5'-O-(thiotriphosphate);
IAB, IAsys biosensor;
GS, gel
shift.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Kowalczykowski, S. C.
(1991)
Annu. Rev. Biophys. Biophys. Chem.
20,
539-575[CrossRef][Medline]
[Order article via Infotrieve] |
| 2. |
Konola, J. T.,
Logan, K. M.,
and Knight, K. L.
(1994)
J. Mol. Biol.
237,
20-34[CrossRef][Medline]
[Order article via Infotrieve] |
| 3. |
Roca, A. I.,
and Cox, M. M.
(1997)
Prog. Nucleic Acid Res. Mol. Biol.
56,
129-223[Medline]
[Order article via Infotrieve] |
| 4. |
McEntee, K.,
Weinstock, G. M.,
and Lehman, I. R.
(1981)
J. Biol. Chem.
256,
8835-8844 |
| 5. |
Bryant, F. R.,
Taylor, A. R.,
and Lehman, I. R.
(1985)
J. Biol. Chem.
260,
1196-1202 |
| 6. |
Menetski, J. P.,
and Kowalczykowski, S. C.
(1985)
J. Mol. Biol.
181,
281-295[CrossRef][Medline]
[Order article via Infotrieve] |
| 7. | Stasiak, A., and Egelman, E. H. (1988) in Genetic Recombination (Kucherlapati, R. , and Smith, G. R., eds) , pp. 265-307, American Society for Microbiology, Washington, D. C. |
| 8. |
Weinstock, G. M.,
McEntee, K.,
and Lehman, I. R.
(1981)
J. Biol. Chem.
256,
8850-8855 |
| 9. |
Cotterill, S. M.,
Satterhwait, A. C.,
and Fersht, A. R.
(1982)
Biochemistry
21,
4332-4337[CrossRef][Medline]
[Order article via Infotrieve] |
| 10. |
Tombline, G.,
Shim, K. S.,
and Fishel, R.
(2002)
J. Biol. Chem.
277,
14426-14433 |
| 11. |
Tombline, G.,
and Fishel, R.
(2002)
J. Biol. Chem.
277,
14417-14425 |
| 12. |
Benson, F. E.,
Stasiak, A.,
and West, S. C.
(1994)
EMBO J.
13,
5764-5771[Medline]
[Order article via Infotrieve] |
| 13. |
Brenner, S. L.,
Zlotnick, A.,
and Stafford, W. F., III
(1990)
J. Mol. Biol.
216,
949-964[Medline]
[Order article via Infotrieve] |
| 14. |
Cotterill, S. M.,
and Fersht, A. R.
(1983)
Biochemistry
22,
3525-3531 |
| 15. |
Kuramitsu, S.,
Hamaguchi, K.,
Ogawa, T.,
and Ogawa, H.
(1981)
J. Biochem. (Tokyo)
90,
1033-1045 |
| 16. |
Brenner, S. L.,
Zlotnick, A.,
and Griffith, J. D.
(1988)
J. Mol. Biol.
204,
959-972[CrossRef][Medline]
[Order article via Infotrieve] |
| 17. |
Takahashi, M.
(1989)
J. Biol. Chem.
264,
288-295 |
| 18. |
Morrical, S. W.,
and Cox, M. M.
(1985)
Biochemistry
24,
760-767[CrossRef][Medline]
[Order article via Infotrieve] |
| 19. |
Benight, A. S.,
Wilson, D. H.,
Budzynski, D. M.,
and Goldstein, R. F.
(1991)
Biochimie (Paris)
73,
143-155 |
| 20. |
Masui, R.,
Mikawa, T.,
Kato, R.,
and Kuramitsu, S.
(1998)
Biochemistry
37,
14788-14797[CrossRef][Medline]
[Order article via Infotrieve] |
| 21. |
Story, R. M.,
Weber, I. T.,
and Steitz, T. A.
(1992)
Nature
355,
318-325[CrossRef][Medline]
[Order article via Infotrieve] |
| 22. |
Story, R. M.,
and Steitz, T. A.
(1992)
Nature
355,
374-376[CrossRef][Medline]
[Order article via Infotrieve] |
| 23. |
Nguyen, T. T.,
Muench, K. A.,
and Bryant, F. R.
(1993)
J. Biol. Chem.
268,
3107-3113 |
| 24. |
Skiba, M. C.,
and Knight, K. L.
(1994)
J. Biol. Chem.
269,
3823-3828 |
| 25. |
Kelley, J. A.,
and Knight, K. L.
(1997)
J. Biol. Chem.
272,
25778-25782 |
| 26. |
Hortnagel, K.,
Voloshin, O. N.,
Kinal, H. H., Ma, N.,
Schaffer-Judge, C.,
and Camerini-Otero, R. D.
(1999)
J. Mol. Biol.
286,
1097-1106[CrossRef][Medline]
[Order article via Infotrieve] |
| 27. |
Coleman, D. E.,
Berghuis, A. M.,
Lee, E.,
Linder, M. E.,
Gilman, A. G.,
and Sprang, S. R.
(1994)
Science
265,
1405-1412 |
| 28. |
Brocchieri, L.,
and Karlin, S.
(1998)
J. Mol. Biol.
276,
249-264[CrossRef][Medline]
[Order article via Infotrieve] |
| 29. |
Ogawa, T.,
Shinohara, A.,
Nabetani, A.,
Ikeya, T., Yu, X.,
Egelman, E. H.,
and Ogawa, H.
(1993)
Cold Spring Harbor Symp. Quant. Biol.
58,
567-576 |
| 30. |
Mikawa, T.,
Masui, R.,
Ogawa, T.,
Ogawa, H.,
and Kuramitsu, S.
(1995)
J. Mol. Biol.
250,
471-483[CrossRef][Medline]
[Order article via Infotrieve] |
| 31. |
Kurumizaka, H.,
Aihara, H.,
Ikawa, S.,
Kashima, T.,
Bazemore, L. R.,
Kawasaki, K.,
Sarai, A.,
Radding, C. M.,
and Shibata, T.
(1996)
J. Biol. Chem.
271,
33515-33524 |
| 32. |
Aihara, H.,
Ito, Y.,
Kurumizaka, H.,
Terada, T.,
Yokoyama, S.,
and Shibata, T.
(1997)
J. Mol. Biol.
274,
213-221[CrossRef][Medline]
[Order article via Infotrieve] |
| 33. |
Aihara, H.,
Ito, Y.,
Kurumizaka, H.,
Yokoyama, S.,
and Shibata, T.
(1999)
J. Mol. Biol.
290,
495-504[CrossRef][Medline]
[Order article via Infotrieve] |
| 34. |
Baumann, P.,
Benson, F. E.,
Hajibagheri, N.,
and West, S. C.
(1997)
Mutat. Res. DNA Repair
384,
65-72[CrossRef][Medline]
[Order article via Infotrieve] |
| 35. |
Ellouze, C.,
Kim, H. K.,
Maeshima, K.,
Tuite, E.,
Morimatsu, K.,
Horii, T.,
Mortensen, K.,
Norden, B.,
and Takahashi, M.
(1997)
Biochemistry
36,
13524-13529[CrossRef][Medline]
[Order article via Infotrieve] |
| 36. |
Yu, X.,
Jacobs, S. A.,
West, S. C.,
Ogawa, T.,
and Egelman, E. H.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
8419-8424 |
| 37. |
Baumann, P.,
Benson, F. E.,
and West, S. C.
(1996)
Cell
87,
757-766[CrossRef][Medline]
[Order article via Infotrieve] |
| 38. |
Holmes, V. F.,
Benjamin, K. R.,
Crisona, N. J.,
and Cozzarelli, N. R.
(2001)
Nucleic Acids Res.
29,
5052-5057 |
| 39. |
Sung, P.,
and Robberson, D. L.
(1995)
Cell
82,
453-461[CrossRef][Medline]
[Order article via Infotrieve] |
| 40. |
Namsaraev, E. A.,
and Berg, P.
(2000)
J. Biol. Chem.
275,
3970-3976 |
| 41. |
Rice, K. P.,
Eggler, A. L.,
Sung, P.,
and Cox, M. M.
(2001)
J. Biol. Chem.
276,
38570-38581 |
| 42. |
De Zutter, J. K.,
and Knight, K.
(1999)
J. Mol. Biol.
293,
769-780[CrossRef][Medline]
[Order article via Infotrieve] |
| 43. |
Tsang, S. S.,
Chow, S. A.,
and Radding, C. M.
(1985)
Biochemistry
24,
3226-3232[CrossRef][Medline]
[Order article via Infotrieve] |
| 44. |
Kobayashi, N.,
Knight, K.,
and McEntee, K.
(1987)
Biochemistry
26,
6801-6810[CrossRef][Medline]
[Order article via Infotrieve] |
| 45. |
Benedict, R. C.,
and Kowalczykowski, S. C.
(1988)
J. Biol. Chem.
263,
15513-15520 |
| 46. |
Namsaraev, E. A.,
and Berg, P.
(1998)
Biochemistry
37,
11932-11939[CrossRef][Medline]
[Order article via Infotrieve] |
| 47. |
Schild, D.,
Lio, Y.,
Collins, D. W.,
Tsomondo, T.,
and Chen, D. J.
(2000)
J. Biol. Chem.
275,
16443-16449 |
| 48. |
Thacker, J.
(1999)
Biochimie (Paris)
81,
77-85 |
| 49. |
Thompson, L. H.,
and Schild, D.
(1999)
Biochimie (Paris)
81,
87-105 |